Pharmaceutical marketer price disclosure: Vermont

Vermont law 33 V.S.A. § 2005a requires pharmaceutical marketers to disclose to Vermont doctors and other prescribers the prices of the drugs they market as well as the prices of others drugs in the same therapeutic class.

This page allows those doctors and other prescribers access to this information for applicable products that are manufactured and marketed by AstraZeneca.

Please choose a product from the list, and select either "Long form" or "Short form" below.

Medicine name    
ARIMIDEX® (anastrozole) Tablets Long form (PDF) Short form (PDF)
ATACAND® (candesartan cilexetil) Tablets Long form (PDF) Short form (PDF)
ATACAND HCT® (candesartan cilexetil-hydrochlorothiazide) Tablets Long form (PDF) Short form (PDF)
BRILINTA™ (ticagrelor) Tablets Long form (PDF) Short form (PDF)
CASODEX® (bicalutamide) Tablets Long form (PDF) Short form (PDF)
CRESTOR® (rosuvastatin calcium) Tablets Long form (PDF) Short form (PDF)
DALIRESP® (roflumilast) Tablets Long form (PDF) Short form (PDF)
FARXIGA™ (dapagliflozin) Tablets Long form (PDF) Short form (PDF)
IRESSA® (gefitinib) Tablets Long form (PDF) Short form (PDF)
KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release) Tablets Long form (PDF) Short form (PDF)
LYNPARZA™ (olaparib) Capsules Long form (PDF) Short form (PDF)
MOVANTIK™ (naloxegol) Tablets Long form (PDF) Short form (PDF)
NEXIUM® (esomeprazole magnesium) Delayed-Release Capsules Long form (PDF) Short form (PDF)
ONGLYZA™ (saxagliptin) Tablets Long form (PDF) Short form (PDF)
PRISTIQ® (desvenlafaxine) Extended-Release Tablets Long form (PDF) Short form (PDF)
SEROQUEL® (quetiapine) Tablets Long form (PDF) Short form (PDF)
TAGRISSO™ (osimertinib) Tablets Long form (PDF) Short form (PDF)
TOPROL XL® (metoprolol succinate) Extended-Release Tablets Long form (PDF) Short form (PDF)
XIGDUO™ XR (dapagliflozin and metformin hydrochloride) Tablets Long form (PDF) Short form (PDF)